NetClass Technology Inc (NASDAQ: NTCL) is carving out its niche in the rapidly evolving technology sector with its focus on online professional education platforms. Operating across the People’s Republic of..
Investors with a keen eye on the biotechnology sector may want to take a closer look at Compass Therapeutics, Inc. (NASDAQ: CMPX). This Boston-based, clinical-stage biopharmaceutical company is making waves..
Outset Medical, Inc. (NASDAQ: OM), a trailblazer in the healthcare sector, is making waves with its innovative hemodialysis solutions. Based in San Jose, California, Outset Medical is revolutionizing the medical..
Abeona Therapeutics Inc. (NASDAQ: ABEO) is a name that has been buzzing in the biotechnology sector, particularly for investors seeking high-growth opportunities. With a current market capitalization of $326.89 million,..
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is capturing the attention of investors with its significant growth potential in the biotechnology sector. Specializing in treatments for gastrointestinal diseases, Phathom is poised to..
CytomX Therapeutics, Inc. (CTMX) stands as a compelling investment opportunity within the biotechnology sector, particularly for investors with a keen interest in oncology-focused innovations. Headquartered in South San Francisco, California,..
Benitec Biopharma Inc. (NASDAQ: BNTC) is an intriguing player in the healthcare sector, specifically within the innovative biotechnology industry. As a clinical-stage company, Benitec is carving a niche in the..
Chevron Corporation (NYSE: CVX), a titan in the energy sector with a market capitalization of $310.64 billion, remains a compelling choice for investors seeking stability and income in the oil..
SANUWAVE Health, Inc. (NASDAQ: SNWV), a key player in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative approach to regenerative medicine. Based in..
For investors eyeing the biotechnology sector, Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) represents an intriguing prospect, boasting a compelling 23.56% potential upside according to recent analyst ratings. With a market cap..
Aura Biosciences, Inc. (NASDAQ: AURA), a prominent player in the biotechnology sector, is capturing significant attention from investors, thanks to its groundbreaking approach to cancer treatment and an eye-catching potential..
For investors with an eye on the biotechnology sector, iTeos Therapeutics, Inc. (NASDAQ: ITOS) presents an intriguing opportunity. With its current market capitalization of $446.57 million, iTeos is a clinical-stage..
Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the medical devices industry within the healthcare sector, is garnering attention with a potential upside of nearly 49%. This..
For investors eyeing the healthcare sector, particularly the volatile yet promising biotechnology industry, Alumis Inc. (NASDAQ: ALMS) presents a tantalizing opportunity. The clinical-stage biopharmaceutical company, headquartered in South San Francisco,..
XOMA Royalty Corporation (NASDAQ: XOMA), a biotech royalty aggregator, has captured investor attention with a substantial market cap of $316.17 million and a remarkable potential upside of 144.76%, according to..
Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions arena, holds notable promise for investors seeking opportunities within the healthcare sector. With a market capitalization of..
Alpha Teknova, Inc. (NASDAQ: TKNO), a key player in the healthcare sector specializing in drug manufacturing, is capturing investor attention with a potential upside of 129.89%. Despite its current stock..
Nano-X Imaging Ltd. (NASDAQ: NNOX), an innovative player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge tomographic imaging technology. Headquartered in Petah Tikva,..
TruBridge, Inc. (NASDAQ: TBRG), a key player in the healthcare information services industry, has captured the attention of investors with a notable potential upside of 37.13%. This potential is driven..
Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to tackling genetically defined diseases. With a current market capitalization..
